<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.1//EN"
  "http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en">
<head>
<meta name="generator" content="jemdoc, see http://jemdoc.jaboc.net/" />
<meta http-equiv="Content-Type" content="text/html;charset=utf-8" />
<link rel="stylesheet" href="jemdoc.css" type="text/css" />
<title></title>
</head>
<body>
<table summary="Table for page layout." id="tlayout">
<tr valign="top">
<td id="layout-menu">
<div class="menu-category">Navigation</div>
<div class="menu-item"><a href="index.html">Home</a></div>
<div class="menu-item"><a href="publications.html" class="current">Publications</a></div>
<div class="menu-item"><a href="software.html">Software</a></div>
</td>
<td id="layout-content">
 <h2>Technical Reports</h2>
    <ul>
<li><p>Zhang, L. and <b>Ma, W.</b> (2025) Efficient interaction analysis in randomized controlled trials. </p>
</li>   
<li><p>Yu, H., <b>Ma, W.</b>, and Liu, H. (2025). Minimax optimal design with spillover and carryover effects. 
  <a href="https://arxiv.org/abs/2501.14602">[arXiv:2501.14602]</a></p></li>
              <li>
            <p>
                Gu, Y., Liu, H., and <b>Ma, W.</b> (2024). Incorporating external data for analyzing randomized clinical trials: A transfer learning approach. 
                <a href="https://arxiv.org/abs/2409.04126">[arXiv:2409.04126]</a>
            </p>
        </li>
              <li>
            <p>
                Li, H., <b>Ma, W.</b>, Ma, Y., and Liu, H. (2024). Treatment effect estimation under covariate-adaptive randomization with heavy-tailed outcomes. 
                <a href="https://arxiv.org/abs/2407.05001">[arXiv:2407.05001]</a>
            </p>
        </li>
              <li>
            <p>
                Xin, J., Liu, H., and <b>Ma, W.</b> (2024). Inference under covariate-adaptive randomization with many strata. 
                <a href="https://arxiv.org/abs/2405.18856">[arXiv:2405.18856]</a>
            </p>
        </li>
    </ul>
<h2>Papers</h2>
<h3>Statistical Theory and Methodology</h3>
<ul>
<li><p>Xin, J. and <b>Ma, W.</b> (2025) On the achievability of efficiency bounds for covariate-adjusted response-adaptive randomization. <i>Statistical Methods in Medical Research</i>, in press.</p>
</li>
<li><p>Liu, X., Hu, F., and <b>Ma, W.</b> (2025) The properties of covariate-adaptive randomization procedures with possibly unequal allocation ratio. <i>The Annals of Applied Statistics</i>, 19(2), 907&ndash;925.</p>
</li>
<li><p>Tu, F. and <b>Ma, W.</b> (2025) Covariate-adjusted inference for doubly-adaptive biased coin design. <i>Statistical Methods in Medical Research</i>, in press.</p>
</li>
<li><p>Zhang, L. and <b>Ma, W.</b> (2025) Interaction tests with covariate-adaptive randomization. <i>Statistical Analysis and Data Mining: The ASA Data Science Journal</i>, 18(1), e70003.</p>
</li>
<li><p>Wang, T. and <b>Ma, W.</b> (2025) The impact of misclassification on covariate-adaptive randomized clinical trials with generalized linear models. <i>Journal of Statistical Planning and Inference</i>, 234, 106209.</p>
</li>
<li><p>Gao, J., Hu, F., and <b>Ma, W.</b> (2024) Response-adaptive randomization procedure in clinical trials with surrogate endpoints. <i>Statistics in Medicine</i>, 43(30), 5911&ndash;5921.
</p>
</li>
<li><p>Tu, F., <b>Ma, W.</b>, and Liu, H. (2024) A unified framework for covariate adjustment under stratified randomization. <i>Stat</i>, 13(4), e70016.</p>
</li>
<li><p>Ye, X., Hu, F., and <b>Ma, W.</b> (2024) Robustness of response-adaptive randomization. <i>Biometrics</i>, 80(2), ujae049.
</p>
</li>
<li><p><b>Ma, W.</b>, Li, P., Zhang, L. X., and Hu, F. (2024) A new and unified family of covariate adaptive randomization procedures and their properties. <i>Journal of the American Statistical Association</i>, 119(545), 151&ndash;162.
</p>
</li>
<li><p>Qin, Y., Li, Y., <b>Ma, W.</b>, Yang, H., and Hu, F. (2024) Adaptive randomization via Mahalanobis distance. <i>Statistica Sinica</i>, 34(1), 353&ndash;375.
</p>
</li>
<li><p>Gu, Y., Liu, H., and <b>Ma, W.</b> (2023) Regression-based multiple treatment effect estimation under covariate-adaptive randomization. <i>Biometrics</i>, 79(4), 2869&ndash;2880.
</p>
</li>
<li><p><b>Ma, W.</b>, Ye, X., Tu, F., and Hu, F. (2023) carat: An R package for covariate-adaptive randomization in clinical trials. <i>Journal of Statistical Software</i>, 102(2), 1&ndash;47.
</p>
</li>
<li><p>Liu, H., Tu, F., and <b>Ma, W.</b> (2023) Lasso-adjusted treatment effect estimation under covariate-adaptive randomization. <i>Biometrika</i>, 110(2), 431&ndash;447.
</p>
</li>
<li><p>Wang, T., He, K., <b>Ma, W.</b>, Bandyopadhyay, D., and Sinha, S. (2023) Minorize-maximize algorithm  for the generalized odds rate model for clustered current status data. <i>Canadian Journal of Statistics</i>, 51(4), 1150&ndash;1170.
</p>
</li>
<li><p><b>Ma, W.</b>, Tu, F., and Liu, H. (2022). Regression analysis for covariate-adaptive randomization: A robust and efficient inference perspective. <i>Statistics in Medicine</i>, 41(29), 5645&ndash;5661.
</p>
</li>
<li><p><b>Ma, W.</b>, Wang, M., and Zhu, H. (2022) Seamless phase II/III clinical trials with covariate adaptive randomization. <i>Statistica Sinica</i>, 32(2), 1079&ndash;1098.
</p>
</li>
<li><p>Zhao, W., <b>Ma, W.</b>, Wang, F., and Hu, F. (2022) Incorporating covariates information in adaptive clinical trials for precision medicine. <i>Pharmaceutical Statistics</i>, 21(1), 176&ndash;195.
</p>
</li>
<li><p>Li, Y., <b>Ma, W.</b>, Qin, Y., and Hu, F. (2021) Testing for treatment effect in covariate-adaptive randomized trials with generalized linear models and omitted covariates. <i>Statistical Methods in Medical Research</i>, 30(9), 2148&ndash;2164.
</p>
</li>
<li><p><b>Ma, W.</b>, Zhang, L. X., and Hu, F. (2021)  Comment on &lsquo;Inference after covariate-adaptive randomisation: aspects of methodology and theory&rsquo;. <i>Statistical Theory and Related Fields</i>, 5(3), 187&ndash;189.
</p>
</li>
<li><p>Li, X., <b>Ma, W.</b>, and Hu, F. (2021) Sample size re‐estimation for covariate‐adaptive randomized clinical trials. <i>Statistics in Medicine</i>, 40(12), 2839&ndash;2851.
</p>
</li>
<li><p>Wang, T. and <b>Ma, W.</b> (2021) The impact of misclassification on covariate-adaptive randomized clinical trials. <i>Biometrics</i>, 77(2), 451&ndash;464.
</p>
</li>
<li><p>Gao, J., <b>Ma, W.</b>, Cheung, S. H., and Hu, F. (2020) Response-adaptive randomization in clinical trials: Recent advances and future perspectives. <i>Journal of Applied Statistics and Management</i>, 39(4), 595&ndash;610.
</p>
</li>
<li><p><b>Ma, W.</b>, Qin, Y., Li, Y., and Hu, F. (2020) Statistical inference for covariate-adaptive randomization procedures. <i>Journal of the American Statistical Association</i>, 115(531), 1488&ndash;1497.
</p>
</li>
<li><p>Hu, F., Hu, Y., <b>Ma, W.</b>, Zhang L. X., and Zhu, H. (2015) Statistical inference of adaptive randomized clinical trials for personalized medicine. <i>Clinical Investigation</i>, 5(4), 415&ndash;425.
</p>
</li>
<li><p><b>Ma, W.</b>, Hu, F., and Zhang, L. X. (2015) Testing hypotheses of covariate-adaptive randomized clinical trials. <i>Journal of the American Statistical Association</i>, 110(510), 669&ndash;680.
</p>
</li>
</ul>
<h3>Medicine, Biology and Public Health</h3>
<ul>
<li><p>Cui, J., Pang, J., Zhang, L., Li, J., Wu, X., Zhu, X., <b>Ma, W.</b>, Luo, S., Gao, H., Wang, Z., and Cai, J. (2024) Peng Zu study on healthy aging in China (Peng Zu cohort): Design and goals. <i>China CDC Weekly</i>, 6(34), 876&ndash;882.
</p>
</li>
<li><p>Liang, W., Yang, Y., Gong, S., Wei, M., Ma, Y., Feng, R., Gao, J., Liu, X., Tu, F., <b>Ma, W.</b>, Yi, X., Liang, Z., Wang, F., Wang, L., Chen, D., Shu, W., E. Miller, B., Tal-Singer, R., Donaldson, G., Wedzicha, J., Singh, D., Wilkinson, T., Brightling, C., Chen, R., Zhong, N., Wang, Z. (2023) Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease. <i>Cell Host & Microbe</i>, 31(6), 1054&ndash;1070.
</p>
</li>
<li><p>Yan, Z., Chen, B., Yang, Y., Yi, X., Wei, M., Ecklu-Mensah, G., Bushmann, M., Liu, H., Gao, J., Liang, W., Liu, X., Yang, J., <b>Ma, W.</b>, Liang, Z., Wang, F., Chen, D., Wang, L., Shi, W., Stampfli, M. R., Li, P., Gong, S., Chen, X., Shu, W., El-Omar, E. M., Gilbert, J. A., Blaser, M. J., Zhou, H., Chen, R., and Wang, Z. (2022) Multi-omics analyses of airway host-microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions. <i>Nature Microbiology</i>, 7, 1361&ndash;1375.
</p>
</li>
<li><p>Wang, Z., Locantore, N.,  Haldar, K., Ramsheh, M., Beech, A., <b>Ma, W.</b>, Brown, J., Tal-Singer, R., Barer, M., Bafadhel, M., Donaldson, G., Wedzicha, J., Singh, D., Wilkinson, T., Miller, B., and Brightling, C. (2021) Inflammatory endotype–associated airway microbiome in chronic obstructive pulmonary disease clinical stability and exacerbations: A multicohort longitudinal analysis.  <i>American Journal of Respiratory and Critical Care Medicine</i>, 203(12), 1488&ndash;1502.
</p>
</li>
<li><p>Zhang, Y., Liu, M., Wu, S. S., Jiang, H., Zhang, J., Wang, S., <b>Ma, W.</b>, Li, Q., Ma, Y., Liu, Y., Feng, W., Amsalu, E., Li, X., Wang, W., Li, W., and Guo, X. (2019) Spatial distribution of tuberculosis and its association with meteorological factors in mainland China.  <i>BMC Infectious Diseases</i>, 19, 379.
</p>
</li>
<li><p>Cohan, S., Kappos, L., Giovannoni, G., Wiendl, H., Selmaj, K., Havrdova, E., Rose, J., Greenberg, S., Phillips, G., <b>Ma, W.</b>, Wang, P., Lima, G., and Sabatella, G. (2018) Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE. <i>Multiple Sclerosis Journal</i>, 24(14), 1883&ndash;1891.
</p>
</li>
</ul>
<h3>Educational Data Mining and Learning Analytics</h3>
<ul>
<li><p>Baker, R. S., <b>Ma, W.</b>, Zhao, Y., Wang, S., and Ma, Z. (2020) The results of implementing zone of proximal development on learning outcomes. In <i>Proceedings of the 13th International Conference on Educational Data Mining</i>, 749&ndash;753.
</p>
</li>
<li><p>Zou, X., <b>Ma, W.</b>, Ma, Z., and Baker, R. S. (2019) Towards helping teachers select optimal content for students. In <i>Proceedings of the 20th International Conference on Artificial Intelligence in Education</i>, 413&ndash;417.
</p>
</li>
<li><p>Baker, R. S., Wang, F., Ma, Z., <b>Ma, W.</b>, and Zheng, S. (2018) Studying the effectiveness of an online language learning platform in China. <i>Journal of Interactive Learning Research</i>, 29(1), 5&ndash;24.
</p>
</li>
</ul>
<h2>Posters at Medical Conferences</h2>
<ul>
<li><p>Giovannoni, G., Ziemssen, T., <b>Ma, W.</b>, and Fam, S. Daclizumab HYP efficacy on disease outcome measures using an expanded definition of highly active relapsing-remitting multiple sclerosis: Results from SELECT and DECIDE. <i>Congress of the European Academy of Neurology</i>, Copenhagen, Denmark, May 2016.
</p>
</li>
<li><p>Fam, S., McCroskery, P., <b>Ma, W.</b>, Chiodo, L., and Sabatella, G. Liver transaminase elevations in the DECIDE study of daclizumab HYP versus intramuscular interferon beta-1a. <i>Congress of the European Academy of Neurology</i>, Copenhagen, Denmark, May 2016.
</p>
</li>
<li><p>Elkins, J., Kappos, L., Selmaj, K., <b>Ma, W.</b>, and Riester, K. Tentative and confirmed disability progression in MS clinical trials. <i>American Academy of Neurology Annual Meeting</i>, Vancouver, Canada, Apr 2016.
</p>
</li>
<li><p>Arnold, D., Kappos, L., Khan, O., Gauthier, S., Greenberg, S., <b>Ma, W.</b>, Wang, P., Elkins, J., and Sabatella, G. Reduction in brain volume loss in patients receiving daclizumab HYP versus intramuscular interferon beta-1a: Results of the DECIDE study. <i>Congress of the European Committee for Treatment and Research in Multiple Sclerosis</i>, Barcelona, Spain, Oct 2015.
</p>
</li>
<li><p>Cohan, S., Kappos, L., Selmaj, K., Havrdova, E., Kaufman, M., Rose, J., Greenberg, S., Amaravadi, L., <b>Ma, W.</b>, and Elkins, J. Efficacy of daclizumab HYP vs intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE. <i>Congress of the European Committee for Treatment and Research in Multiple Sclerosis</i>, Barcelona, Spain, Oct 2015.
</p>
</li>
<li><p>Kaufman, M., Kappos, L., Selmaj, K., Arnold, D., Havrdova, E., Boyko, A., Wiendl, H., Rose, J., Greenberg, S., Sweetser, M., <b>Ma, W.</b>, Wang, P., and Beatty, M. The effect of daclizumab high-yield process (DAC HYP) on patient-centered functional outcomes: Results from the DECIDE study. <i>Consortium of Multiple Sclerosis Centers Annual Meeting</i>, Indianapolis, IN, May 2015.
</p>
</li>
</ul>
</td>
</tr>
</table>
</body>
</html>
